Lindbrook Capital’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,000
Closed -$19.1K 2741
2022
Q2
$19K Hold
1,000
﹤0.01% 987
2022
Q1
$21K Sell
1,000
-1,000
-50% -$21.2K ﹤0.01% 983
2021
Q4
$48K Hold
2,000
0.01% 733
2021
Q3
$51K Hold
2,000
0.01% 435
2021
Q2
$51K Sell
2,000
-500
-20% -$12.3K 0.01% 470
2021
Q1
$61K Hold
2,500
0.01% 378
2020
Q4
$60K Buy
+2,500
New +$54.3K 0.01% 351
2020
Q3
Sell
-11,850
Closed -$250K 1787
2020
Q2
$253K Sell
11,850
-1,950
-14% -$39.7K 0.08% 102
2020
Q1
$246K Buy
13,800
+2,600
+23% +$51.3K 0.09% 91
2019
Q4
$234K Buy
11,200
+6,200
+124% +$123K 0.08% 120
2019
Q3
$92K Buy
5,000
+1,000
+25% +$19.3K 0.03% 254
2019
Q2
$80K Hold
4,000
0.03% 275
2019
Q1
$82K Buy
4,000
+2,000
+100% +$40.9K 0.03% 261
2018
Q4
$35K Buy
+2,000
New +$40.9K 0.02% 451

Other funds holding HQH

Lindbrook Capital's HQH Position: Q3 2022 in Review

Lindbrook Capital sold out of abrdn Healthcare Investors (HQH) in Q3 2022, closing a stake of 1,000 shares — an estimated $19.1K sold.

Lindbrook Capital first reported a position in HQH in Q4 2018 and held it in 14 quarters. The position peaked at $253K in Q2 2020. 105 funds tracked by Wall St. Rank hold HQH as of Q3 2022.

  • Lindbrook Capital reported no remaining abrdn Healthcare Investors position as of Q3 2022 after selling out during the quarter.
  • Lindbrook Capital sold 1,000 abrdn Healthcare Investors shares in Q3 2022, an estimated $19.1K.
  • Lindbrook Capital first reported a position in abrdn Healthcare Investors in Q4 2018 and held it in 14 quarters.
  • Lindbrook Capital's abrdn Healthcare Investors position peaked at $253K in Q2 2020.
  • 105 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2022.

Based on Lindbrook Capital's 13F filing for Q3 2022, filed 10 Nov 2022.